Definium Therapeutics has reported positive Phase III results for its LSD-based medicine DT120 in generalised anxiety disorder, giving the company...

As Australia looks back on National Pain Week, held from 26–31 July, attention remains focused on one of the country's...

As psychedelic-assisted therapy moves from research into clinical practice in Australia, the organisations building the infrastructure around the sector are...

Fiji is destroying cannabis plants by the tens of thousands while simultaneously preparing for the possibility that the same plant...

A growing body of research has suggested that meditation and psychedelic medicines may share more in common than previously believed....

The next phase of psychedelic drug development may not involve psychedelics in the traditional sense. As researchers and pharmaceutical companies...

When Australia became the first country to permit authorised psychiatrists to prescribe MDMA and psilocybin for specific mental health conditions...

Australian psychedelic biotechnology company Entropy Neurodynamics (ASX: ENP) has secured Human Research Ethics Committee (HREC) approval to begin what it...

Few stories in modern drug development begin with an anonymous underground pamphlet, a manual typewriter and a desert toad. Yet...

For more than a decade, Hamilton Morris has occupied a unique position in the world of psychedelic science. He is...